The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension. [PDF]
Parkinsonism Relat Disord, 2020 Palma JA +7 more
europepmc +1 more source
A validated test for neurogenic orthostatic hypotension at the bedside. [PDF]
Ann Neurol, 2018 Norcliffe-Kaufmann L +2 more
europepmc +1 more source
Management of Orthostatic Hypotension with Supine Hypertension [PDF]
, 2022 Argawal, Megha, Canan, Timothy
core
Management of coexistent neurogenic orthostatic hypotension and supine hypertension. [PDF]
J Clin Hypertens (Greenwich), 2019 Cannom DS.
europepmc +1 more source
Six-Month Use of Droxidopa for Neurogenic Orthostatic Hypotension. [PDF]
Mov Disord Clin Pract, 2019 François C +11 more
europepmc +1 more source
Synergistic Pressor Effect of Atomoxetine and Pyridostigmine in Patients With Neurogenic Orthostatic Hypotension. [PDF]
Hypertension, 2019 Okamoto LE +7 more
europepmc +1 more source
Neglected cause of recurrent syncope: a case report of neurogenic orthostatic hypotension. [PDF]
Eur Heart J Case Rep, 2019 Miller RJH, Chew DS, Raj SR.
europepmc +1 more source
Use of droxidopa for the long-term treatment of neurogenic orthostatic hypotension. [PDF]
Eur Heart J, 2019 Raj SR, Hewitt LA.
europepmc +1 more source
Utility of autonomic testing for the efficient diagnosis and effective pharmacological management of neurogenic orthostatic hypotension. [PDF]
BMJ Case Rep, 2019 Alam SB, Almardini W, Suleman A.
europepmc +1 more source
Cognitive and Behavioral Changes in Patients Treated With Droxidopa for Neurogenic Orthostatic Hypotension: A Retrospective Review. [PDF]
Cogn Behav Neurol, 2019 McDonell KE +5 more
europepmc +1 more source